Financial strategy

• Business Value
  
  A European affiliate of one of the major top 5 global pharmaceutical companies was considering partial divestment of a generics company to a key Indian- based player. We supported the client by assessing the value of the business on a stand-alone basis and also with various collaborative structures in place with differing equity ownership structures.
  
  This helped the client to fully understand their negotiating position and the business value range to effectively manage the transaction process. The valuation was primarily driven from DCF methodologies and scenario analysis, although various market benchmarks were used as a secondary reconciliation.
  
  
• Value proposition for shareholders
  
  A UK-based specialist women's healthcare company sought support to ensure that their overall value growth strategy was aligned with shareholder expectations. We performed a number of existing and future state analysis based on development of the company's existing portfolio and proved that the company's existing drug products could satisfy the likely shareholder value requirements without the need for a major acquisition transaction or merger.
  
  
• Financial Due Diligence
  
  A large US based biotechnology company was planning to purchase a EU- based company. They asked us to perform 3 sets of short lists and to provide them with a list of top 3 companies based on good valuation and strategic fit. We found that most of the companies were privately held and therefore with limited financial data in the public domain. This was not a friendly acquisition therefore; we did not have access to the target company's data financial records.
  
  We developed screening criteria to short-list 10 possible candidate companies and we performed in-depth due diligence on the top3. We came up with a proprietary technique to compare and contrast valuation of private companies with similar size-listed companies.
  
  We provided a range value for the target company and made clear recommendations based on multi- attribute criteria.